Education
About Us
Working with TipRanks
Follow Us
Formycon AG (DE:FYB)
XETRA:FYB
Fyb201 0.5 Mg (0.05 Ml Of 10 Mg/Ml)
Age-Related Macular Degeneration, Branch Retinal Vein Occlusion With Macular Edema, Central Retinal Vein Occlusion With Macular Edema
Phase IV
Completed
Ocular Safety and Usability Study for FYB201 PFS
Nov 25, 2024
―
Fyb203 2 Mg (0.05 Ml Of 40 Mg/Ml)
Diabetic Macular Edema, Age-Related Macular Degeneration, Diabetic Retinopathy, Branch Retinal Vein Occlusion With Macular Edema, Central Retinal Vein Occlusion With Macular Edema
Phase IV
Completed
Ocular Safety and Usability Study for FYB203 PFS
Nov 25, 2024
―
Fyb206, Keytruda
Non-Squamous Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer
Phase III
Terminated
Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC)
Oct 13, 2024
―
Fyb206, Keytruda
Melanoma Stage Iii, Melanoma, Stage Ii
Phase I
Active Not Recruiting
Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients
Aug 09, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Formycon AG (FYB) have in its pipeline
FYB is currently developing the following drugs: Fyb201 0.5 Mg (0.05 Ml Of 10 Mg/Ml), Fyb203 2 Mg (0.05 Ml Of 40 Mg/Ml), Fyb206, Keytruda. These drug candidates are in various stages of clinical development as the company works toward FDA approval.